{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-022266","form_type":"8-K","ticker":"JANX","cik":"0001817713","company_name":"Janux Therapeutics, Inc.","filed_at":"2024-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.662444+00:00","generated_at":"2026-06-05T09:21:39.023474+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Janux Therapeutics suspends ATM equity offering program","bullets":["Delivered written notice to BofA on Feb 28, 2024 suspending the ATM prospectus supplement.","No further sales of common stock under the Sales Agreement until a new prospectus supplement is filed.","Sales Agreement remains in full force and effect; suspension does not terminate it."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-022266","json":"https://secwatch.observer/filing/0000950170-24-022266.json","markdown":"https://secwatch.observer/filing/0000950170-24-022266.md","text":"https://secwatch.observer/filing/0000950170-24-022266.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817713/000095017024022266/0000950170-24-022266-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817713/000095017024022266/janx-20240228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T09:21:39.023474+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}